2018 Results

TMCX INVESTMENT PRIZE + ACCELERATOR ADMISSION

VITLS

VITLS
Vitls has developed a revolutionary platform that enables healthcare providers to continuously and remotely monitor a patient’s vital signs, in the most unobtrusive way possible. Their wearable collects body temperature, pulse, respiration rate, O2 saturation, sleep, & movement for up to 6 days.

TMCX ACCELERATOR ADMISSION

VENOSTENT

VENOSTENT
A JLABS startup company born from Vanderbilt University IP, VenoStent, Inc. is developing a shape memory polymer external stent to improve the quality and length of life for the >2 million – and growing – dialysis patients worldwide.